IDEXX Laboratories, Inc. IDXX | NASDAQ

$470.07 -$1.32 | -0.28%

Company Overview:

Market Cap: $38.09B
PE Ratio: 43.36
52-Week Range: $356.14 - $548.88

10 Year Performance Metrics:

Total Return (with DRIP): 622.31% (21.86% / yr)
Total Return (no DRIP): 622.31% (21.86% / yr)
Share Price: 622.31%
IDXX Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

IDXX Earnings, Revenue, Cash & Debt, Shares Outstaning:

IDXX - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
IDXX - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IDXX - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IDXX - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
IDXX - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
IDXX - Cash & Debt
14-Day FREE Trial Get Full Access Now!
IDXX - Revenue
14-Day FREE Trial Get Full Access Now!
IDXX Revenue CAGR:1Y: 5.84%2Y: 7.32%5Y: 9.53%10Y: 10.49%
IDXX - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
IDXX EPS CAGR:1Y: 12.07%2Y: 12.62%5Y: 20.11%10Y: 25.42%
IDXX - Net Income
14-Day FREE Trial Get Full Access Now!
IDXX Net Income CAGR:1Y: 11.12%2Y: 12.03%5Y: 19.02%10Y: 23.61%
IDXX - EBITDA
14-Day FREE Trial Get Full Access Now!
IDXX EBITDA CAGR:1Y: 7.48%2Y: 14.62%5Y: 20.81%10Y: 23.94%
IDXX - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
IDXX Free Cash Flow CAGR:1Y: 2.52%2Y: 28.84%5Y: 15.26%10Y: 37.41%
IDXX - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
IDXX Free Cash Flow / Share CAGR:1Y: 3.50%2Y: 29.33%5Y: 16.24%10Y: 39.47%
IDXX - Gross Profit
14-Day FREE Trial Get Full Access Now!
IDXX Gross Profit CAGR:1Y: 8.46%2Y: 8.48%5Y: 11.50%10Y: 12.10%
IDXX - Expenses
14-Day FREE Trial Get Full Access Now!
IDXX Expenses CAGR:1Y: 20.58%2Y: 0.03%5Y: -3.08%10Y: 8.10%
IDXX - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
IDXX Shares Outstanding CAGR:1Y: -1.04%2Y: -0.45%5Y: -0.97%10Y: -1.53%
IDXX - Share Buybacks
14-Day FREE Trial Get Full Access Now!
IDXX Share Buybacks CAGR:1Y: 567.55%2Y: 82.23%5Y: 11.82%10Y: 5.13%
IDXX - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
IDXX Stock-Based Comp CAGR:1Y: -6.34%2Y: 3.62%5Y: -3.06%10Y: 11.89%
IDXX - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
IDXX Revenue CAGR:1Y: 5.84%2Y: 7.32%5Y: 9.53%10Y: 10.49%
IDXX - Revenue by Region
14-Day FREE Trial Get Full Access Now!
IDXX Revenue CAGR:1Y: 5.84%2Y: 7.32%5Y: 9.53%10Y: 10.49%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

IDXX - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual Revenue CAGR:1Y: 5.84%2Y: 7.32%5Y: 9.53%10Y: 10.49%
IDXX - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual EPS CAGR:1Y: 12.07%2Y: 12.62%5Y: 20.11%10Y: 25.42%
IDXX - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual Net Income CAGR:1Y: 11.12%2Y: 12.03%5Y: 19.02%10Y: 23.61%
IDXX - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual EBITDA CAGR:1Y: 7.48%2Y: 14.62%5Y: 20.81%10Y: 23.94%

Ratios, Profit Margins & Return on Capital:

IDXX - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
IDXX Net Profit Margin CAGR:1Y: 4.96%2Y: 4.40%5Y: 8.66%10Y: 11.87%
IDXX - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
IDXX Gross Profit Margin CAGR:1Y: 2.47%2Y: 1.08%5Y: 1.80%10Y: 1.45%
IDXX - Price to Earnings
14-Day FREE Trial Get Full Access Now!
IDXX - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
IDXX - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
IDXX - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for IDXX

Based on past 10-year performance, here are IDXX growth metrics:

Share price CAGR of +21.64%
Dividend CAGR of +0%

Using IDXX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

IDXX (DRIP)IDXX - No DRIP
Current Price$471.38$471.38
Start Shares21.2121.21
Start Value$10,000$10,000
  
After 10 years:
Final Share Count21.2121.21
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$2,748.16$471.38
Total Dividends$0$0
Final Value$58,300$10,000

Estimated Future Value + Dividends - IDXX

NOTE: Above numbers are our estimate based on IDXX's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

IDEXX Laboratories, Inc. (IDXX) had its IPO on 1991-06-21, and is trader on NASDAQ stock exchange.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX website: https://www.idexx.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial